Delivery Order SPE2DB22D2206-SPE2DB24FFJ55
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $2,578.82 for the supply of TIVICAY 50 MG TABLET 30S. The contract has an ultimate completion date of February 28, 2024 and uses a Firm Fixed Price pricing type. The award is associated with a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $34,328.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TIVICAY 50 MG TABLET 30S, a pharmaceutical product, with a completion date of April 28, 2023. This is a firm fixed-price delivery order contract, and no set-aside designation was used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical...
- This federal contract award, valued at $14,550.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of TIVICAY 50 MG TABLET 30S. The contract, a Delivery Order with a Firm Fixed Price, has an ultimate completion date of April 12, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a critical supplier of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $41,667.43, is for the delivery of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of February 15, 2024 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
- This contract award, valued at $20,596.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TIVICAY 50 MG TABLET 30S, a pharmaceutical product, with a completion date of May 19, 2023. The contract is a Delivery Order under a Firm Fixed Price arrangement. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $15,933.25, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of the pharmaceutical product TIVICAY 50 MG TABLET 30S, with a completion date of December 4, 2023. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TIVICAY 50 MG TABLET 30S. The fixed-price delivery order, valued at $33,068.24, has a completion date of May 7, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice...
- This federal contract award, valued at $8,030.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4556688419 - TIVICAY 50 MG TABLET 30S, a prescription medication. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award, valued at $16,319.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TIVICAY 50 MG TABLET 30S, a pharmaceutical product, and has an ultimate completion date of November 5, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $2,452.24, is for the delivery of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price Delivery Order, with an ultimate completion date of April 19, 2023. This contract award is not designated as a set-aside contract....
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFJ55Delivery Order
This federal contract award, valued at $35,728.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2024 and utilizes a Firm Fixed Price pricing type. This award is not associated with any set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp, the prime contractor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.7k | 1/30/24 |